Pathogenesis of human immunodeficiency virus-induced neurological disease.
about
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene deliveryImpact of cocaine abuse on HIV pathogenesisMonocytes as regulators of inflammation and HIV-related comorbidities during cARTHIV Associated Neurocognitive DisordersHIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidaseHuman endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disordersEvidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementiaFactors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.Cerebrospinal fluid viral load and intrathecal immune activation in individuals infected with different HIV-1 genetic subtypesHIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes.Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.Retrograde and anterograde transport of HIV protein gp120 in the nervous system.Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transportImpact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcomeCirculating proviral HIV DNA and HIV-associated dementia.HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1Protective effects of curcumin against human immunodeficiency virus 1 gp120 V3 loop-induced neuronal injury in rats.Neuroinvasion of the highly pathogenic influenza virus H7N1 is caused by disruption of the blood brain barrier in an avian model.Snip-snip, kill-kill: truncated SDF-1 and HIV-associated neurodegeneration.Humanized mouse models for HIV-1 infection of the CNS.White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patientsCurcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop.Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques.Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HANDMorphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophagesInvestigation of adenovirus occurrence in pediatric tumor entities.Regional cortical thinning associated with detectable levels of HIV DNA.When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy.Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicityProgramming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator.Mechanism(s) involved in opioid drug abuse modulation of HANDHIV proviral DNA associated with decreased neuropsychological functionCell-cell contact viral transfer contributes to HIV infection and persistence in astrocytesActivation status of integrated stress response pathways in neurones and astrocytes of HIV-associated neurocognitive disorders (HAND) cortex.
P2860
Q24804110-3E8B307B-DA17-48AF-B279-F54F85EC2CF3Q26779435-9A670C7B-52F3-4F2B-80DA-1F20B4A942E0Q27006827-2102ECAC-2593-4B9E-95A6-B54195D946C4Q27023968-96E24CF3-A05F-4D82-B0EC-9E5C872CC00EQ28261913-84F5B711-1C97-4201-A499-C27790568882Q28769517-A6D023AC-F370-46EE-B54E-7ACB14872260Q30936809-728CC239-07DA-45D4-B0C0-15B9AD25AFF9Q33311631-C633786E-64DC-4B6D-A4DE-8EAF48C09EFAQ33328489-9DBDC2B6-E806-4BE0-9AEF-D12ECEE0CB24Q33455734-DEC16F31-0EC5-403B-A428-CB1886897832Q33647684-CE707480-83C3-4EA6-AD17-0229CE9B3A72Q33802715-AED349E7-D4BC-4B0F-9F77-EDCCC51A2454Q33843510-8B83CEDB-72BA-4FE3-A86D-6B23B135B102Q33870898-F2D9B9F3-645C-4636-8EAD-BE0AEE2E4CF8Q34033558-CFCE00BB-382B-416E-88AB-2303016A3703Q34037622-029AA5DC-C5AE-4B36-BFC9-0A8C6BA5775BQ34193846-5D989C4B-9968-4713-8D97-3AA81A943263Q34450960-330A9907-CDEB-4A2E-9729-E389A2A13966Q34634294-6B1A7252-2985-49A2-B134-69EC10623C23Q35012478-03C57829-0F65-4D06-8FBC-411E865356BCQ35031037-4025F40B-C64B-4879-9C86-FE54C9995A46Q35157729-BA650968-210C-46B2-B150-D3EA35730D59Q35519758-4F3D2AD1-8DCE-4E0E-8DFB-11AF73E2162AQ35545058-9202629E-D63E-4126-B1E6-D765859F1FF1Q35567215-CE633E31-EBBD-46C0-9096-2590DBDAE714Q35828301-F4B4F394-4C99-4023-BA44-6D002C0B221EQ35837978-CE1368A1-4D5C-4D0C-A5BB-E2A118CEEEB3Q35886296-64ED5315-1715-41B1-9626-AB4A05117C4AQ35901271-FB5E2889-A66B-4A16-B0D7-38BB543B6AE8Q35911433-0753EECD-0550-4A4A-B6F0-22155F70DC37Q35914457-E774F9F9-567E-4B13-83D9-E343AF96688FQ36142331-761A19B7-DF3A-4F54-BE15-3E27CE36F31DQ36188164-63172377-08A9-4380-889C-6B1CD17CC766Q36283322-EEDAC1FA-C73C-4083-84B6-FA128CE52E41Q36296748-E92CE8F7-BC30-408B-A204-DEDA168ABC11Q36498596-1DB0A720-5D32-4723-B9BF-8083D7B744B7Q36590733-A2DB30B9-AAB8-406F-804E-C2DDCB35CD71Q36683785-BE5FF90B-1920-44ED-83D8-FE45A1739BE4Q36883462-AFD294EC-5828-492A-86F0-1C468BC0FCB3Q37003222-42FB07B7-69C0-4A82-908E-3FE02156005F
P2860
Pathogenesis of human immunodeficiency virus-induced neurological disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pathogenesis of human immunodeficiency virus-induced neurological disease.
@ast
Pathogenesis of human immunodeficiency virus-induced neurological disease.
@en
type
label
Pathogenesis of human immunodeficiency virus-induced neurological disease.
@ast
Pathogenesis of human immunodeficiency virus-induced neurological disease.
@en
prefLabel
Pathogenesis of human immunodeficiency virus-induced neurological disease.
@ast
Pathogenesis of human immunodeficiency virus-induced neurological disease.
@en
P2093
P1476
Pathogenesis of human immunodeficiency virus-induced neurological disease.
@en
P2093
Andrew V Albright
Francisco González-Scarano
Samantha S Soldan
P2888
P304
P356
10.1080/13550280390194073
P577
2003-04-01T00:00:00Z
P5875
P6179
1041156610